525 related articles for article (PubMed ID: 23842215)
61. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
Zhao J; Yuan C; Wang D; Li X
Chin Med J (Engl); 2000 Jan; 113(1):27-30. PubMed ID: 11775204
[TBL] [Abstract][Full Text] [Related]
62. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
Pozzi M; Osculati G; Boari G; Serboli P; Colombo P; Lambrughi C; De Ceglia S; Roffi L; Piperno A; Cusa EN
Gastroenterology; 1994 Mar; 106(3):709-19. PubMed ID: 8119542
[TBL] [Abstract][Full Text] [Related]
63. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
64. Alcoholic cirrhosis-associated hepatorenal syndrome treated with vasoactive agents.
Esrailian E; Runyon BA
Nat Clin Pract Nephrol; 2006 Mar; 2(3):169-72. PubMed ID: 16932415
[TBL] [Abstract][Full Text] [Related]
65. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
66. Management of refractory ascites.
Singhal S; Baikati KK; Jabbour II; Anand S
Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
[TBL] [Abstract][Full Text] [Related]
67. [Massive paracentesis and administration of dextran 70 vs albumin in cirrhotic patients with tense ascites].
Hernández Pérez RE; Aguilar Ramírez JR; Hernández López JM; Gómez Maganda y Silva TG
Rev Gastroenterol Mex; 1995; 60(1):22-6. PubMed ID: 7543691
[TBL] [Abstract][Full Text] [Related]
68. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Awal S; Yadav J; Awal L; Davis B; Kashiouris MG; Cable CA
Ann Hepatol; 2021 Dec; 26():100547. PubMed ID: 34626828
[TBL] [Abstract][Full Text] [Related]
69. [Therapeutic paracentesis with albumin infusion for the treatment of tension ascites in cirrhotic patients. Preliminary report].
García Compean D; Pérez Martínez C; Guerra JM; Barragán RF
Rev Gastroenterol Mex; 1990; 55(1):7-12. PubMed ID: 2291066
[TBL] [Abstract][Full Text] [Related]
70. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Ginés P; Arroyo V; Quintero E; Planas R; Bory F; Cabrera J; Rimola A; Viver J; Camps J; Jiménez W
Gastroenterology; 1987 Aug; 93(2):234-41. PubMed ID: 3297907
[TBL] [Abstract][Full Text] [Related]
71. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
72. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
[TBL] [Abstract][Full Text] [Related]
73. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.
Sorrentino P; Castaldo G; Tarantino L; Bracigliano A; Perrella A; Perrella O; Fiorentino F; Vecchione R; D' Angelo S
J Gastroenterol Hepatol; 2012 Apr; 27(4):813-22. PubMed ID: 22142548
[TBL] [Abstract][Full Text] [Related]
74. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial.
García-Compeán D; Zacarías Villarreal J; Bahena Cuevas H; García Cantú DA; Estrella M; Garza Tamez E; Valadez Castillo R; Barragán RF
Liver; 1993 Oct; 13(5):233-8. PubMed ID: 8259034
[TBL] [Abstract][Full Text] [Related]
75. Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT.
Ashritha A; Lal BB; Khanna R; Sood V; Sood AK; Alam S
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):350-359. PubMed ID: 38374552
[TBL] [Abstract][Full Text] [Related]
76. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
[TBL] [Abstract][Full Text] [Related]
77. Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
Ali A; Farid S; Amin M; Kassem M; Al-Garem N
Hepatogastroenterology; 2014 Oct; 61(135):1915-24. PubMed ID: 25713888
[TBL] [Abstract][Full Text] [Related]
78. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
[TBL] [Abstract][Full Text] [Related]
79. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
[TBL] [Abstract][Full Text] [Related]
80. Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
Bai Z; An Y; Guo X; Teschke R; Méndez-Sánchez N; Li H; Qi X
Can J Gastroenterol Hepatol; 2020; 2020():5106958. PubMed ID: 32676484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
